FischerBCruzM FirestoneRehmJ.Illicit opioid use and its key characteristics: A select overview and evidence from a Canadian multisite cohort of illicit opioid users (OPICAN). Can J Psychiatry. 2006;51:624–634.
2.
OyemadeA.Re: Illicit opioid use and its key characteristics: A select overview and evidence from a Canadian multisite cohort of illicit opioid users [letter]. Can J Psychiatry. 2007;52(5):335.
3.
AmatoLDavoliMPerucciCAn overview of systematic reviews of the effectiveness of opiate maintenance therapies: Available evidence to inform clinical practice and research. J Subst Abuse Treat. 2005;28:321–329.
4.
BarnettPRodgersJBlochD.A meta-analysis comparing buprenorphine to methadone for treatment of opiate dependence. Addiction. 2001;96:683.
5.
CaplehornJDeeksJ.A critical appraisal of the Australian comparative trial of methadone and buprenorphine maintenance. Drug Alcohol Rev. 2006;25:157–160.
6.
FischerBRehmJKimGEyes wide shut? A conceptual and empirical critique of methadone maintenance treatment. Eur Addict Res. 2005;11:1–12.
7.
BestDHarrisJGossopMUse of non-prescribed methadone and other illicit drugs during methadone maintenance treatment. Drug Alcohol Rev. 2000;19:9–16.
8.
OrtnerRPeternellAKraigherDCocaine abuse in maintenance therapy with methadone in narcotic dependent patients. Wiener Klinische Wochenschrift. 2001;113:934–938.
9.
GrellaCAnglinMWugalterS.Patterns and predictors of cocaine and crack use by clients in standard and enhanced methadone maintenance treatment. Am J Drug Alcohol Abuse. 1997;23:15–42.
10.
FischerBChinAKuoICanadian illicit opiate users' views on methadone and other opiate prescription treatment: An exploratory qualitative study. Subst Use Misuse. 2002;37:495–522.
